Department of Obstetrics and Gynecology, Division of Gynecology (Drs Chang-Patel and Gould).
Department of Obstetrics and Gynecology, Oregon Health and Science University (Dr Wong), Portland, Oregon.
J Minim Invasive Gynecol. 2024 Mar;31(3):237-242. doi: 10.1016/j.jmig.2023.12.013. Epub 2023 Dec 25.
To examine the effect of transversus abdominis plane (TAP) block timing (preoperative or postoperative) on postoperative opioid use (quantified via morphine milligram equivalents; MME) and pain scores in patients undergoing minimally invasive hysterectomy for benign indications.
Retrospective, single-institution cohort study SETTING: Academic-affiliated community hospital PATIENTS: A total of 2982 patients were included who underwent a minimally invasive total hysterectomy between January 2018 and December 2022, excluding patients with a malignancy diagnosis, concurrent urogynecological procedure, vaginal hysterectomy, supracervical hysterectomy, or those with baseline narcotic use (opioid use within the 3 months before surgery). Patients were separated into 3 groups: no TAP blocks (n = 1966, 65.9%), preoperative TAP blocks (854, 28.6%), and postoperative TAP blocks (162, 5.4%).
Summary statistics and mixed-effects regression methods were used for data analysis.
There was a statistically significant lower mean use of opioids (MME 43.2 vs 53.9, p = .002) among patients who received a TAP block (either pre or postoperatively) than those who did not receive a block. However, when comparing preoperative vs postoperative patients with TAP block, there was no statistically significant difference in mean opioid use (MME 43.4 vs 42.1, p = .752). There were no differences in postoperative pain scores between patients with and without a TAP block, however, more opioids were required in patients who did not receive a TAP block to achieve the same pain scores as those who did receive a TAP block. There was a statistically significant shorter time to discharge for TAP versus patients without TAP block(median 5.5 vs 6.3 hours, p ≤ .001) as well as preoperative versus postoperative patients with TAP block (median 5.3 vs 6.2 hours, p = .001).
While TAP block use at the time of minimally invasive hysterectomy reduced use of postoperative opioids, the timing of TAP block, either preoperatively or postoperatively, did not significantly affect opioid use. Preoperative compared with postoperative TAP block administration significantly shortened the time to discharge.
探讨腹横肌平面(TAP)阻滞的时机(术前或术后)对接受微创子宫切除术治疗良性疾病的患者术后阿片类药物使用(通过吗啡毫克当量;MME 量化)和疼痛评分的影响。
回顾性、单机构队列研究
学术附属社区医院
2018 年 1 月至 2022 年 12 月期间共纳入 2982 例接受微创全子宫切除术的患者,排除恶性肿瘤诊断、同期妇科泌尿手术、阴道子宫切除术、经宫颈子宫切除术或基线使用麻醉性镇痛药(手术前 3 个月内使用阿片类药物)的患者。患者分为 3 组:无 TAP 阻滞(n=1966,65.9%)、术前 TAP 阻滞(n=854,28.6%)和术后 TAP 阻滞(n=162,5.4%)。
采用汇总统计和混合效应回归方法进行数据分析。
与未接受 TAP 阻滞的患者相比,接受 TAP 阻滞(无论是术前还是术后)的患者阿片类药物(MME 43.2 对 53.9,p=0.002)的平均使用量有统计学显著降低。然而,比较术前和术后 TAP 阻滞患者时,阿片类药物的平均使用量(MME 43.4 对 42.1,p=0.752)无统计学显著差异。接受和不接受 TAP 阻滞的患者之间的术后疼痛评分无差异,但不接受 TAP 阻滞的患者需要更多的阿片类药物来达到与接受 TAP 阻滞的患者相同的疼痛评分。与无 TAP 阻滞的患者相比,TAP 组的出院时间明显更短(中位数 5.5 对 6.3 小时,p≤0.001),术前 TAP 阻滞与术后 TAP 阻滞患者相比(中位数 5.3 对 6.2 小时,p=0.001)。
微创子宫切除术中 TAP 阻滞的使用减少了术后阿片类药物的使用,但 TAP 阻滞的时机(术前或术后)并不显著影响阿片类药物的使用。与术后 TAP 阻滞相比,术前 TAP 阻滞给药显著缩短了出院时间。